ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Inhibrx Announces Agreement for INBRX-101 outside US, Canada with Chiesi Group
May 31, 2019Inhibrx has entered into an agreement with Chiesi Farmaceutici. The agreement grants Chiesi Group an option to exclusively license, develop and commercialize INBRX-101 outside of ... -
Chiesi Group has presented data at two international congresses on the role of its extrafine formulation ICS/LABA/LAMA vs LABA/LAMA in the treatment of COPD patients
May 30, 2018Chiesi Group (Chiesi), an international research-focussed healthcare company, was present at the American Thoracic Society (ATS) meeting in San Diego (18-23 May 2018) and at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Ann
Pharma Sources Insight January 2025
